Rare disease · Glycogen storage
Pompe QSP v2.0
ERT optimisation across LOPD, IOPD CRIM+ and IOPD CRIM− populations.
Model description
ERT optimisation across LOPD, IOPD CRIM+ and IOPD CRIM− populations.
What can be done with this model
- Avalglucosidase and cipaglucosidase + miglustat regimens
- CRIM-status stratification and ITI benefit
- Hex4, 6MWT and FVC endpoint mapping
- ASME V&V40-style dossier
Free/open layer
- Model page and publication description
- Selected SBML / bundle artefacts
- Decision table CSV
Subscription layer
- Clinical layer
- Quarterly update and partner scenarios
Downloads and artefacts
No public SBML download has been cleared yet. This page provides the model description and access boundary.